Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF)


Creative Commons License

Fox K. A. A., Accetta G., Pieper K. S., Bassand J., Camm A. J., Fitzmaurice D. A., ...Daha Fazla

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, cilt.4, sa.1, ss.27-35, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 4 Sayı: 1
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1093/ehjqcco/qcx030
  • Dergi Adı: EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.27-35
  • Anahtar Kelimeler: Registries, Atrial fibrillation, Anticoagulation, Retrospective, Prospective, ANTITHROMBOTIC TREATMENT PATTERNS, INFORMED TREATMENT, STROKE, MANAGEMENT, COUNTRIES, PREFER, PERSISTENT, RATIONALE, WARFARIN, EVENTS
  • Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

Aims Retrospective and prospective observational studies are designed to reflect real-world evidence on clinical practice, but can yield conflicting results. The GARFIELD-AF Registry includes both methods of enrolment and allows analysis of differences in patient characteristics and outcomes that may result.